New website offers seamless access to end-to-end solutions that enable clarity and control across the radiopharmaceutical lifecycle
Mirion, a global leader in radiation safety, science, and medicine, today announced the Mirion Radiopharma Solutions website, a streamlined, user-focused platform designed to guide stakeholders across the radiopharmaceutical lifecycle directly to the solutions they need for enhanced operational clarity and control. By integrating hardware and software offerings from Mirion Technologies Health Physics and Spectroscopy lines, along with Mirion Medical brands Capintec, ec2 Software, and Dosimetry Services, Mirion delivers a unified destination for critical, proven solutions.
For Drug Owners and Developers, Isotope Producers, Radiopharmacies, and Hospitals and Clinical Sites, the Mirion Radiopharma Solutions site makes it easy for each audience to navigate by their role, discover relevant solutions, and access supporting resources. Users can efficiently connect with tools that optimize their radiopharmaceutical workflows from discovery through dose.
Key Features and Benefits of the new platform:
- End-to-End Solutions: Comprehensive offerings support every stage of the radiopharmaceutical lifecycle, from research and development to isotope production and radiopharmaceutical operations, to shipping, waste management, and patient care.
- Integrated Solutions for Every Need: Customers can explore a full range of hardware, software, and radiation safety products—all in one place—to find the best combination of tools and technologies for their unique radiopharma operations.
- Stakeholder-Centered Design: The website delivers tailored pathways and resources for every segment of the radiopharma value chain, ensuring Drug Owners and Developers, Isotope Producers, Radiopharmacies, and Hospitals and Clinical Sites can easily access the Mirion solutions most relevant to their needs.
- Unified User Experience: All Mirion Radiopharma products and services are now available through a single online destination, streamlining the search for information and expert support.
Mirion Radiopharma Solutions Featured at Key Medical Conferences
Mirion Medical brand Capintec exhibited at the EANM Annual Congress (European Association of Nuclear Medicine) earlier this month. The congress focused on recent advances in theranostics — a rapidly evolving area that continues to transform diagnosis and treatment to deliver unprecedented precision and personalized care for patients. The event convened researchers and clinicians from every specialty within nuclear medicine, and featured tracks dedicated to clinical practice, research and education.
“This new platform reflects our commitment to supporting stakeholders across the radiopharma value chain, as they work to realize the promise of precision medicine for patients worldwide,” said Mirion Chief Marketing Officer Erin Schesny. “Following the landmark EANM industry gathering, we are proud to showcase the breadth of our solutions and our dedication to advancing radiation medicine and theranostics.”
Mirion will also highlight its radiopharma solutions at the upcoming SNMMI Fall Theranostics Meeting, taking place November 6-8, 2025, in Maryland. This event will provide another opportunity for nuclear medicine professionals to explore how Mirion’s integrated solutions can enhance workflows from discovery through dose preparation.
Discover the new Mirion Radiopharma Solutions website at: mirion.com/radiopharma
About Mirion
Mirion is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. The Mirion Technologies group provides proven radiation safety technologies that operate with precision – for essential work within R&D labs, critical nuclear facilities, and on the front lines. The Mirion Medical group solutions help enhance the delivery and ensure safety in healthcare, powering the fields of Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry, and Diagnostic Imaging. Headquartered in Atlanta (GA – USA), Mirion employs approximately 2,800 people and operates in 12 countries. Learn more at mirion.com.
For media inquiries:
Erin Schesny
[email protected]
For investor inquiries:
Eric Linn
[email protected]
